Overview
Xiangxin Song practices practicing medicine in Ueruemqi, China.
Their clinical expertise encompasses Ovarian Cysts, Polycystic Ovary Syndrome, Pheochromocytoma, and Adrenal Cancer.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xiangxin Song
Is Xiangxin Song a top-rated expert for Ovarian Cysts?
MediFind is an objective health platform that identifies experts based on real-world data. Xiangxin Song is classified as an Experienced expert for Ovarian Cysts, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xiangxin Song participate in research or clinical trials?
Yes. Xiangxin Song has published 8 articles and abstracts on conditions like Ovarian Cysts. You can view a list of Xiangxin Song's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adrenal CancerSong isExperienced. Learn about Adrenal Cancer.
- Ovarian CystsSong isExperienced. Learn about Ovarian Cysts.
- PheochromocytomaSong isExperienced. Learn about Pheochromocytoma.
- Polycystic Ovary SyndromeSong isExperienced. Learn about Polycystic Ovary Syndrome.